August 1997 Cryosurgical Publications

A weekly updated compilation of cryosurgery related publications

August 5thAugust 12thAugust 19thAugust 26th
BIOSYS
MEDLINE

 

August 5th, 1997

BIOSYS Database:
1. BOOK
   Daly, J M.
     Metastatic cancer to the liver.
     De Vita, V. T. Jr., S. Hellman and S. A. Rosenberg (Ed.). Cancer:
   Principles and practice of oncology, 5th edition, Vols. 1 and 2.
   lxix+1539p.(vol. 1); li+1585p.(vol. 2) Lippincott-Raven Publishers:
   Philadelphia, Pennsylvania, USA. ISBN 0-397-51574-X(set); ISBN
   0-397-51575-8(Vol. 1); ISBN 0-397-51576-6(Vol. 2). 1997. p. 2551-2570.

August 5th, 1997

Medline Database:

 

August 12th, 1997

BIOSYS Database:

 

August 12th, 1997

Medline Database:
1. Shumway SJ; Johnson EM; Svendsen CA; Kriett JM; Ring WS.
     Surgical management of ventricular tachycardia.
   Annals of Thoracic Surgery, 1997 Jun, 63(6):1589-91.
       (UI:  97349150)

Abstract: BACKGROUND: Ventricular tachyarrhythmias are the leading cause of
    death from coronary artery disease. A small percentage of these arrhythmias
    originate in chronically ischemic myocardium, rather than acutely ischemic
    myocardium, and can be refractory to medical management. Epicardial mapping
    and focal cryoablation of foci demonstrating early activation may provide
    definitive therapy when pharmacologic management fails. We report a series
    of 42 consecutive patients with refractory ventricular tachycardia (VT) who
    were treated with open epicardial mapping and focal cryoablation after
    pharmacologic management failed. METHODS: We retrospectively reviewed the
    records of patients who underwent surgical treatment of malignant VT. For
    patients not recently seen in the clinic, we conducted telephone
    interviews. At the time of operation, epicardial mapping was performed to
    locate foci of early electrical activation. These foci were then
    cryoablated, using 2-minute applications of liquid nitrogen-cooled probes.
    All patients underwent postoperative electrophysiologic studies to test for
    inducible VT. RESULTS: Of these 42 patients, 34 (81%) were male, 8 (19%)
    female. Average age was 62.9 +/- 10.6 years; ejection fraction, 0.20
    (range, 0.04 to 0.50); and number of foci ablated, 2.1 +/- 1.1 (range, 1 to
    6). At the time of cryoablation, all patients underwent additional
    procedures, including aneurysmectomy, coronary artery bypass, or valve
    replacement. The 30-day operative mortality was 9.5% (4 of 42). Of the 38
    survivors, 36 (94.7%) were clinically free of VT; the remaining 2 had
    spontaneous or inducible VT. CONCLUSIONS: Open cryoablation of foci
    propagating VT appears to be safe and effective. It may be the most
    definitive treatment for malignant VT.

2. Jester DM.
     Office procedures. Cryotherapy of dermal abnormalities.
   Primary Care; Clinics in Office Practice, 1997 Jun, 24(2):269-80.
     Pub type:  Journal Article; Review; Review, Tutorial.
       (UI:  97319011)

Abstract: Cryotherapy of dermal abnormalities is a commonly used technique in
    the field of primary care. To perform cryotherapy effectively, one must
    understand the principles of cryoablation and how they apply to specific
    skin disorders. One also must be familiar with the various types of
    equipment that are used to perform cryotherapy. With this understanding
    cryotherapy easily can be integrated into outpatient primary care.

3. Zhou XD; Tang ZY.
     Management of hepatocellular carcinoma: long-term outcome in 2639 cases.
   Gan To Kagaku Ryoho Japanese Journal of Cancer and Chemotherapy, 1997 May,
   24 Suppl 1:9-16.
     Pub type:  Journal Article; Review; Review, Tutorial.
       (UI:  97354656)

Abstract: This paper reports the progress of management in 2639 patients with
    pathologically proven primary liver cancer (PLC) over the past three
    decades, and the factors improving long-term outcome. The 5-, and 10-year
    survival after resection of PLC was 45.9% and 34.8%, respectively, for the
    whole series (n = 1826), and 61.3% and 45.7%, respectively, for patients
    with small PLC (< = 5 cm, n = 645). The 5-year survival after cryosurgery
    was 37.9% for the whole series (n = 191), and 53.1% for patients with small
    PLC (n = 56). The 5-year survival of 73 patients receiving sequential
    resection after cytoreduction therapy was 67.8%. The 5-year survival after
    re-resection for recurrence tumor (n = 148) was 34.5%; 239 patients
    survived more than 5 years; 124 of these patients (51.9%) were small PLC,
    and 63 patients survived more than 10 years. Encouraging changes in the
    prognostic pattern were observed when the PLC data of 1958-1970 (n = 178),
    1971-1982 (n = 582) and 1983-1994 (n = 1879) were compared; the 5-year
    survival being 4.8%, 11.2% and 45.4%, respectively, and the 10-year
    survival being 4.2%, 7.5% and 34.6%, respectively. Some aspects to prolong
    survival further were discussed.

4. Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD.
     Three decades' experience in surgery of hepatocellular carcinoma.
   Gan To Kagaku Ryoho Japanese Journal of Cancer and Chemotherapy, 1997 May,
   24 Suppl 1:126-33.
       (UI:  97354668)

Abstract: In the author's institution, 2254 patients with hepatocellular
    carcinoma (HCC) have been treated during 1958-1994. The overall 5-year
    survival increased from 5.4% (1958-1970), to 11.9% (1971-1982), to 46.2%
    (1983-1984), which correlated well with the increasing proportion of small
    HCC in the series (2.6%, 12.1%, and 33.4%, respectively); with the
    increasing percentage of limited resection (3.1%, 32.2%, and 58.3%); with
    the increasing number of re-resections for recurrence (0, 27, and 114
    patients); and with the increasing number of second stage resections (0, 5,
    and 67 patients). In our institution, surgical approaches that resulted in
    significantly prolonging survival included: small HCC resection,
    re-resection, and cytoreduction followed by sequential resection for
    initially unresectable HCC. Experience in these 3 aspects suggests: (a)
    Small HCCs are mainly found by screening using AFP and ultrasonography (US)
    in a high risk population, and limited resection is the best treatment in
    patients with compensated liver cirrhosis, the 5-year survival after
    resection being 62.9% (n = 549). (b) Postoperative monitoring using AFP/US
    every 2-3 months for 5-10 years after curative resection is needed to
    detect subclinical recurrence. Limited re-resection is indicated for liver
    recurrence less than 3 nodules, and lung lobectomy is of proven merit to
    prolong survival for solitary lung metastasis. Re-resection of subclinical
    recurrence has resulted in a 10-20% further increase in 5-year survival
    after curative resection. (c) Palliative surgery other than resection such
    as hepatic artery ligation (HAL) and cannulation with arterial infusion
    (HAI), cryosurgery, etc. are superior to palliative resection with residual
    cancer. (d) Cytoreduction and sequential resection have provided hope for
    localized unresectable HCC, particularly in the right cirrhotic liver.
    Multimodality combination treatments such as
    HAL+HAI+radioimmunotherapy/regional radiotherapy are acceptable
    cytoreductive therapies. Repeated transcatheter hepatic arterial
    chemoembolization (TACE) is an alternative nonsurgical approach. Sequential
    resection is important to eradicate residual cancer after cytoreduction.
    The 5-year survival of 72 patients with cytoreduction and sequential
    resection for initially unresectable HCC was 62.1% and resulted in
    improving 5-year survival in the entire series of unresectable HCC over the
    3 periods from 0% to 7.4% to 25.7%, respectively. However, multicentric
    origin and tumor invasiveness are two major targets to be studied in the
    control of recurrence and metastasis.

5. Rabin Y; Shitzer A.
     Combined solution of the inverse Stefan problem for successive
     freezing/thawing in nonideal biological tissues.
   Journal of Biomechanical Engineering, 1997 May, 119(2):146-52.
       (UI:  97311674)

Abstract: A new combined solution of the one-dimensional inverse Stefan problem
    in biological tissues is presented. The tissue is assumed to be a nonideal
    material in which phase transition occurs over a temperature range. The
    solution includes the thermal effects of blood perfusion and metabolic heat
    generation. The analysis combines a heat balance integral solution in the
    frozen region and a numerical enthalpy-based solution approach in the
    unfrozen region. The subregion of phase transition is included in the
    unfrozen region. Thermal effects of blood perfusion and metabolic heat
    generation are assumed to be temperature dependent and present in the
    unfrozen region only. An arbitrary initial condition is assumed that
    renders the solution useful for cryosurgical applications employing
    repeated freezing/thawing cycles. Very good agreement is obtained between
    the combined and an exact solution of a similar problem with constant
    thermophysical properties and a uniform initial condition. The solution
    indicated that blood perfusion does not appreciably affect either the shape
    of the temperature forcing function on the cryoprobe or the location and
    depth of penetration of the freezing front in peripheral tissues. It does,
    however, have a major influence on the freezing/thawing cycle duration,
    which is most pronounced during the thawing stage. The cooling rate imposed
    at the freezing front also has a major inverse effect on the duration of
    the freezing/thawing.

6. Maslova IV; Onufrieva EK.
     [Treatment of children with congenital diseases of the larynx and
     trachea].
   Vestnik Otorinolaringologii, 1997(3):46-8.
     Language:  Russian.
       (UI:  97339772)

Abstract: +33 cases of vascular tumors, 15 of congenital membranes, 12 of
    papillomatosis, 5 of cysts, 12 of abnormal laryngeal cartilages, 3 of
    tracheomalacia, 9 of stridor, 1 of fibrous polyp and 1 of mucous membrane
    folding in the interarytenoid region are reported. Operative interventions
    primarily endoscopic laser surgery were performed in children with
    congenital vascular tumors, membranes, cysts. Removal of papillomas in
    congenital papillomatosis conducted with the use of micro-instruments and
    CO2-laser was combined with immunomodulation. Children with laryngeal
    cartilage anomalies, tracheomalacia and stridor were subjected to prolonged
    nasotracheal intubation of even tracheotomy only in case of severe
    respiratory failure..

  

August 19th, 1997

BIOSYS Database:
1. Diller, K R.
     Engineering-based contributions in cryobiology.
     Cryobiology, v.34, n.4, (1997): 304-314.

Abstract:
     Over the past three decades there has been an increasing number of
     engineering-trained researchers who have made the field of cryobiology a
     primary focus of their work. In prior times the advances in cryobiology
     were accomplished nearly exclusively by members of the life and medical
     science communities. In general, the practice of engineering may be
     distinguished by two features: an emphasis on rigorous quantitative
     measurement and analysis of processes and the synthesis of an
     understanding of fundamental principles of nature into the design of novel
     devices and processes for specific applications. One area of focus in
     cryobiology that engineers have emphasized is the design of new apparatus,
     including both experimental instrumentation and clinical diagnostic and
     therapeutic devices. There has been a broad spectrum of new apparatus
     invented to enable the quantitative control and measurement of the
     fundamental phenomena that govern processes in cryobiology. Among these
     are low-temperature cryomicroscopy stages and mass diffusion chambers,
     which now are often used in conjunction with digital image analysis
     algorithms to quantify changes to individual cells and tissues elicited
     during the process being studied. Other applications include the
     development of novel measurement techniques for assessing system
     properties and states during freezing and thawing. In cryosurgery and in
     cryopreservation new probes and apparatus have been designed to provide
     more accurate and effective processes to achieve clinical objectives.
     Equally important and complementary to the design of hardware is the
     development of analytical models which can be applied to understand and
     interpret experimental data and to predict the behavior of systems for
     operation in domains beyond those for which empirical data are available.
     Perhaps the most critical role of these models is for inverse solution
     techniques with experimental data to obtain values for the intrinsic
     constitutive properties of tissues which govern their response to freezing
     and thawing processes.

2. Smith, M D; Downie, J B; Dicostanzo, D.
     Granuloma annulare.
     International Journal of Dermatology, v.36, n.5, (1997): 326-333.

3. Baust, J; Gage, A A; Ma, H; Zhang, C-M.
     Minimally invasive cryosurgery: Technological advances.
     Cryobiology, v.34, n.4, (1997): 373-384.

Abstract:
     The technological advances which have caused renewed interest in
     cryosurgery are the development of intraoperative ultrasound to monitor
     the therapeutic process and the development of new cryosurgical equipment
     designed to use supercooled liquid nitrogen. The thin, highly efficient
     probes, available in several sizes, can be placed in diseased sites via
     endoscopy or percutaneously in minimally invasive procedures. The manner
     of use is to place the probe in the desired location in the diseased
     tissue with ultrasound guidance. If required by the size or location of
     the tumor, as many as five probes can be inserted and cooled to - 195
     degree C simultaneously. The process of freezing is monitored by
     ultrasound which displays a hypoechoic (dark) image when the tissue if
     frozen. Rapid freezing, slow thawing, and repetition of the freeze/thaw
     cycle are standard features of technique. Clinical applications which have
     become common in the past 4 years include the treatment of prostatic
     cancer and liver tumors. The cases selected for cryosurgery are generally
     those for which no conventional treatment is possible. However, especially
     in prostatic cancer, the operative morbidity is so low and the results of
     therapy are sufficiently good in the short term to merit consideration of
     use in earlier stages of the disease. Diverse tumors in other sites, such
     as the brain, bronchus, bone, pancreas, kidney, and uterus, have also been
     treated in small numbers by cryosurgery. Judging from this experience,
     further expansion in the use of cryosurgical techniques seems certain.

4. Tezuka, T; Kohriyama, K; Tsujii, Y; Tatsuta, N; Sugiyama, Y; Yamada, H.
     A case of giant strawberry mark with high risk of the occurrence of
   deprivation amblyopia by the closure of eyelid with a bloody crust.
     Hifu, v.39, n.2, (1997): 177-180.
     Language:  Japanese.

Abstract:
     A two-month-old female baby with a giant strawberry mark on her left,
     upper and lower eyelids is reported. Following ophthalmologic examination,
     erosion occurred on her eyelid. Her left eyelid was closed by a bloody
     crust for 3 weeks. As deprivation amblyopia was suspected, urgent surgery
     to lift her left eyelid with a nylon suture was performed and epidermis
     obtained by a suction blister was transplanted to the erosion. Eight years
     later, the lesion had completely disappeared and skin with almost normal
     texture was obtained by several cryosurgical and dye laser treatments.

5. Marcushamer, M; King, D L; Ruano, N S.
     Cryosurgery in the management of mucoceles in children.
     Pediatric Dentistry, v.19, n.4, (1997): 292-293.

6. Holman, M R; Rowland, S J.
     Design and development of a new cryosurgical instrument utilizing the
   Peltier thermoelectric effect.
     Journal of Medical Engineering & Technology, v.21, n.3-4, (1997): 106-110.

Abstract:
     Warts and some other dermatological conditions may be treated by the
     application of intense cold. This freezing has to be so severe as to form
     ice crystals which will rupture the cell membranes. The initial part of
     this project was to investigate the feasibility of using Peltier
     thermoelectric coolers (TECs) to cool down a suitable hand-held treatment
     tip to a temperature of approximately - 50 degree C. The results of these
     initial experiments showed how this could be accomplished and a prototype
     cryosurgical instrument, suitable for clinical trials, was designed and
     constructed. This new design is freestanding, self-contained and is
     operated from a standard 230 V mains supply. Unlike existing systems it
     does not use any disposable gases or liquids. A cryoprobe of this new
     design would allow reliable cryosurgery to be performed in a GP's
     treatment room where supplies of liquid nitrogen, nitrous oxide or carbon
     dixoide are not readily available. The design also has a built-in
     thermometer to measure the treatment tip temperature thus ensuring
     consistency in treatment. Clinical trials are being conducted at a number
     of GP practices to evaluate this new design.

7. Johnson, L B; Krebs, T S; Wong, J J; Daly, B; Kuo, P C; Plotkin, J S; Njoku,
   M; Van Echo, D.
     Preoperative mapping with MRI predicts complete ablation by cryosurgery in
   patients with hepatic metastases. (Digestive Disease Week and the 97th
   Annual Meeting of the American Gastroenterological Association,...
     Gastroenterology, v.112, n.4 SUPPL., (1997): A1452.

8. Korpan, N N; Hochwarter, G.
     Pancreatic cryosurgery: A new surgical procedure for pancreatic cancer.
   (31st Annual Scientific Meeting of the European Society for Clinical
   Investigation, Kiel, Germany, March 19-22, 1997. )
     European Journal of Clinical Investigation, v.27, n.SUPPL. 1, (1997): A33.

9. Rabin, Y; Julian, T B; Wolmark, N.
     A compact cryosurgical apparatus for minimally invasive procedures.
     Biomedical Instrumentation & Technology, v.31, n.3, (1997): 251-258.

Abstract:
     A new liquid-nitrogen-based apparatus for minimally invasive cryosurgery
     is presented. The cryoprobe was designed for application to breast tumors;
     however, it can be used for the treatment of other tumors. The cryoprobe
     has three major components, a cryoneedle, a thermal insulation shell, and
     a protective tube, which may be assembled as part of the operation. This
     special assembly keeps destruction to surrounding tissues due to cryoprobe
     penetration minimal, and allows accurate localization of the cryoprobe tip
     by means of stereotactic or needle-localization techniques. An alternative
     cryoprobe consists of a cryoneedle and a thermal insulation shell, which
     are rigidly connected. The liquid nitrogen supply system has two major
     components, an air-pressure source and a liquid nitrogen container, which
     are physically separated. This special configuration allows placement of
     the liquid nitrogen container adjacent to the cryotreated tissue and
     decreases the length of the cryoprobe feeding tube. In turn, heat losses
     to the surroundings are reduced, and therefore coolant consumption is
     reduced. The short feeding tube allows safe operation at low pressures.
     The small size of the apparatus makes it attractive for cryosurgical
     operations. It has been evaluated in gelatin solutions and in porcine
     skeletal muscle and liver. In-vivo results do not differ significantly
     from those obtained in gelatin solutions with regard to the dimensions of
     frozen regions. Using a three cryoprobe configuration, a frozen region
     with an average diameter of 50 mm and a length of 75 mm was obtained
     within 11 minutes. The thermal efficiency of that procedure was found to
     be 43%.

10. Shields, J A; Shields, C L; De Potter, P.
      Surgical management of conjunctival tumors: The 1994 Lynn B. McMahan
    lecture.
      Archives of Ophthalmology, v.115, n.6, (1997): 808-815.

Abstract:
      To our knowledge, there are no articles that describe the specific
      step-by-step details of the surgical removal of premalignant and
      malignant conjunctival tumors. We describe our current approach to the
      surgical management of squamous cell carcinoma (intraepithelial or
      invasive), localized melanoma, and primary acquired melanosis of the
      conjunctiva. The surgical method differs with limbal tumors, extralimbal
      tumors, and primary acquired melanosis. Limbal lesions are managed by
      localized alcohol corneal epitheliectomy, removal of the main mass by a
      partial lamellar scleroconjunctivectomy, and supplemental cryotherapy.
      Tumors located in the extralimbal conjunctiva are managed by alcohol
      application, wide circumferential surgical resection, and cryotherapy.
      Primary acquired melanosis is managed by alcohol epitheliectomy, removal
      of suspicious foci, quadrantic staging biopsies, and cryotherapy from the
      underside of the conjunctiva. In all cases, a" no touch" method is used
      and direct manipulation of the tumor is avoided to Prevent tumor cell
      seeding into a new area. We have employed this technique on 109 patients
      with conjunctival squamous neoplasms and 137 patients with conjunctival
      melanoma, about 80 of which neoplasms were associated with primary
      acquired melanosis. Our observations suggest that well-planned initial
      surgical management using this technique decreases the chance of tumor
      recurrence for conjunctival melanoma and squamous cell carcinoma. We
      describe a detailed stepwise approach to the surgical management of
      conjunctival neoplasms. It requires meticulous clinical evaluation and
      complete removal of the tumor in one operation using a specific
      technique.

11. Lee, F; Bahn, D K; McHugh, T A; Kumar, A A; Badalament, R A.
      Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and
    temperature monitoring: A one year follow-up.
      Anticancer Research, v.17, n.3A, (1997): 1511-1516.

Abstract:
      Objective: To determine the clinical outcomes at one year of Stages T2-T3
      prostate cancer by cryosurgery utilizing pretreatment with total androgen
      ablation therapy and temperature monitoring to control the freezing
      process. Study Group: To date, 347 patients have had 356 cryosurgical
      procedures. 280 have reached one year post treatment. Of these, 131 had
      re-evaluation with prostatic biopsy and serum PSA. Methods: Transrectal
      ultrasound (TRUS) measurement of tumor size and biopsy of extraprostatic
      space was used to stage patients into two main groups: confined (66.6%)
      versus nonconfined (19.3%). Radiation failures (14.1%) formed a separate
      group. Failure rates for the 131 men include all cancer diagnosed during
      the one year period following cryosurgery. Results: The one year failure
      rate for the study group was 19.8% (26/131). For stages T2a, T2b C, T3
      and radiation failures, the rates ofpositive biopsies were 13.9%, 12.9%,
      33.3% and 35%, respectively. For those with local control of cancer
      (negative biopsy), 80% had prostate specific antigen (PSA) levels of lt
      0.5 ng/Ml The statistical variables for persistent cancer with prostate
      specific antigen gt 0.5 ng/ml were: sensitivity of 66.7%, PPV of 16.7%,
      NPV of 98% and specificity of 83.7%. A statistically significant
      difference exists between stages T2 vs T3 and radiation failures (p= lt
      0.5). Major complications of rectal fistula and total incontinence for
      previously non-treated cancer versus radiation failures were 0.33% and
      8.7% respectively, a 26 times greater risk Conclusion: Results of
      cryosurgery for all stages of prostate cancer at one year are
      encouraging, being 80% free of disease (biopsy and prostate specific
      antigen). The morbidity of the previously non-treated cancers from this
      procedure for us was minimal with high patient acceptance. For radiation
      failures a local control rate of 65% was achieved. However, early in our
      experience significant morbidity did occur and our enthusiasm for
      attempted salvage was initially tempered.

12. Schreuder, H W B; Van Egmond, J; Van Beem, H B H; Veth, R P H.
      Monitoring during cryosurgery of bone tumors.
      Journal of Surgical Oncology, v.65, n.1, (1997): 40-45.

Abstract:
      Background: Cryosurgery is used in orthopaedic oncology as adjuvant
      treatment after intralesional excision of bone tumors to induce cell
      death at and beyond the surgical margin. Monitoring freeze/thaw cycles
      during cryosurgery is beneficial in controlling a cryosurgical procedure
      and in preventing an unwarranted local extent of the freeze. Method: We
      conducted a study of 15 cryosurgical procedures with the use of a
      protocolized temperature measuring system with peroperative graphic
      visualization. Results: Using a liquid nitrogen spray, intralesional
      temperatures of -150 degree C were achieved, which are, according to the
      literature, associated with cell death. Extralesional temperature
      measurements showed no subzero temperatures of surrounding important
      tissues. Conclusions: Temperature recordings in and outside the lesion
      during cryosurgery in orthopaedic oncology are of importance to monitor
      the freeze/thaw cycles and are helpful in facilitating an effective
      cryosurgical procedure and in controlling the extent of the freeze,
      avoiding local complications.

August 19th, 1997

Medline Database:
1. Schmidt JD.
     Transperineal ultrasound-guided prostate cryosurgery.
   Journal of Surgical Oncology, 1997 Jul, 65(3):228-9.
     (UI:  97380134)

2. Kuflik EG; Gage AA.
     Recurrent basal cell carcinoma treated with cryosurgery.
   Journal of the American Academy of Dermatology, 1997 Jul, 37(1):82-4.
       (UI:  97359611)

Abstract: BACKGROUND: Although there are reports of cure rates achieved by
    cryosurgery for primary basal cell carcinomas (BCCs), there are few data on
    the cryosurgical treatment of recurrent BCCs. OBJECTIVE: Our purpose was to
    discuss case selection, cryosurgical management, and results of therapy.
    METHODS: Cryosurgery was performed in 54 patients with 56 recurrent BCCs.
    The treatment consisted of aggressive freezing including an adequate margin
    of surrounding tissue. RESULTS: Wound healing was favorable and the
    cosmetic results were excellent. Two recurrences were found and were
    referred for Mohs micrographic surgery. CONCLUSION: We conclude that
    cryosurgical treatment of selected recurrent BCCs yields results that
    compare favorably with other methods of treatment.

3. Ma L; Zhao B; Di Y.
     [Treatment of neovascular glaucoma by anterior retinal cryotherapy and
     trabeculectomy].
   Chung-Hua Yen Ko Tsa Chih Chinese Journal of Ophthalmology, 1996 Mar,
   32(2):118-22.
     Language:  Chinese.
       (UI:  97350460)

Abstract: OBJECTIVE: To investigate the efficacy of anterior retinal
    cryotherapy (ARC) for treatment of neovascular glaucoma (NVG). METHODS: 12
    eyes (11 patients) with open angle NVG were treated by ARC only, 22 eyes
    (22 patients) with closed angle NVG were treated by ARC combined with
    trabeculectomy, and 32 eyes (31 patients) with closed angle NVG were
    treated by either ARC or cyclocryotherapy as controls. The follow-up period
    were 6-26 months. RESULTS: Iris new vessels (INV) regressed or disappeared
    with normal intraocular pressure (IOP) in 92% (11/12) of the eyes with open
    angle NVG treated simply by ARC. In comparison with closed angle NVG
    treated by the same method, there was a significant difference in IOP (P <
    0.05). The combination of ARC and trabeculectomy showed markedly better
    results than either ARC or cyclocryotherapy for treatment of closed angle
    NVG (P < 0.01). In the eyes with closed angle NVG, INV regressed or
    disappeared with normal IOP in 86% (19/22), 90% (18/20) achieved a marked
    relief from pain and the visual acuity was better or unchanged in 67%
    (8/12) that was significantly different from the eyes treated by
    cyclocryotherapy (P < 0.05). CONCLUSION: The results indicate that ARC is
    suitable for treatment of NVG at early stage, and ARC combined with
    trabeculectomy, at later stage.

4. Ablin RJ.
     What of the clinical significance of the cryoimmune response? [letter].
   Dermatologic Surgery, 1997 Jun, 23(6):499-500.
     Pub type:  Letter.
     (UI:  97360845)

5. Conejo-Mir JS; Moreno JC; Camacho F.
     Cryosurgical treatment of professional chronic radiodermatitis.
   Dermatologic Surgery, 1997 Jun, 23(6):483-6.
       (UI:  97360838)

Abstract: BACKGROUND: Chronic x-ray dermatitis in professionals is a frequent
    problem for doctors in our country due to the fact that many of them widely
    used radiotherapy without any protection 15-20 years ago. Surgery has been
    the most accepted treatment, though it generally decreases hand function.
    OBJECTIVE: Up to now, cryosurgery was not usually considered as a possible
    treatment if the lesions were located on fingers. In this study, the
    advantages of cryosurgery for the treatment of professional chronic
    radiodermatitis with incipient pretumoral lesions are emphasized. METHODS:
    Cryosurgery was performed on six patients affected with chronic
    professional radiodermatitis that showed keratomas and ulcerations, using
    both spray (keratomas) and a probe 0.5 cm in diameter (ulcerations, in situ
    squamous cell carcinoma). Nerve block anesthesia with mepivacaine 1% was
    used in all cases. Before the treatment, all suspected lesions were
    biopsied; if invasive squamous cell carcinoma was revealed in the
    dermatopathological study, the patient was rejected. Variables such as
    blister and necrosis formation, pain, and achromatic, sensibility, and
    mobility disorders were studied. The follow-up period was 2 years. RESULTS:
    Immediate postoperative results showed great pain and blistering in all
    cases. Residual achromias were observed early postoperatively in all cases,
    but were repigmented 1 year after therapy in four cases (66%). Sensory
    alterations (hypo- and hyperthesias) were found in four cases (66%) 1 month
    after treatment, although this complication was not observed 6 months after
    treatment. Finger mobility was perfect in all cases 2 months after
    treatment, and there was no recurrence in any case after 2 years of
    follow-up. CONCLUSIONS: We believe cryosurgery must be considered as an
    excellent treatment for professional chronic radiodermatitis with
    keratomas, ulcerations, and incipient squamous cell carcinomas. Its use may
    prevent further dramatic surgical treatment, like amputations, allowing the
    preservation of finger function.

6. Goncalves JC.
     Fractional cryosurgery. A new technique for basal cell carcinoma of the
     eyelids and periorbital area.
   Dermatologic Surgery, 1997 Jun, 23(6):475-81.
     Pub type:  Journal Article; Review; Review of Reported Cases.
       (UI:  97360837)

Abstract: BACKGROUND: Cryosurgery is an established method to treat malignant
    tumors of the eyelids and periorbital area. Nevertheless, it has been
    abandoned for tumors greater than 10 mm, because it gives irregular
    esthetic results and, in some cases, lagophthalmos. OBJECTIVE: To devise a
    new method for the treatment of such tumors. METHOD: Fractional cryosurgery
    is performed in stages: the center of the lesion is frozen, resulting in a
    reduction of the tumor; this procedure is repeated, as necessary, until the
    lesion's diameter is smaller than 10 mm; the standard cryosurgical
    procedure is then carried out. RESULTS: The treatment of the first 20 basal
    cell carcinomas with diameters between 10 and 24 mm is described, with
    excellent clinical and cosmetic results. CONCLUSION: With fractional
    cryosurgery, the final scar bears no relation to the size of the original
    tumor but, instead, corresponds to the size of the lesion preceding the
    final cryosurgical procedure.

7. Ohtake H; Misaki T; Iwa T; Matsunaga Y; Watanabe G; Takahashi M; Kawasuji M;
       Watanabe Y.
     Postoperative influences of surgical cryoablation for
     Wolff-Parkinson-White syndrome--a analysis of myocardial enzymes and
     function.
   Japanese Circulation Journal, 1997 May, 61(5):396-401.
     Pub type:  Clinical Trial; Journal Article.
       (UI:  97335573)

Abstract: We evaluated postoperative myocardial enzymes and function associated
    with cryoablation in 20 patients with Wolff-Parkinson-White syndrome
    undergoing surgical treatment for a single left-sided accessory conduction
    pathway. Ten patients underwent endocardial atrial incision with
    cryoablation using CO2 at -60 degrees C for 120 sec (group A), while the
    remaining 10 patients did not receive cryoablation (group B). Levels of
    aspartate aminotransferase (GOT), lactate dehydrogenase (LDH), and creatine
    kinase (CK-MB) on postoperative days 1, 2, and 3 were higher in patients in
    group A than in group B (p < 0.05). However, mean values remained low (GOT,
    120.5 IU/L; LDH, 1105.1 IU/L; CK-MB, 76.3 IU/L). No electrocardiographic
    changes were detected. Parameters of cardiac function, including cardiac
    index, stroke volume index, systemic vascular resistance, and ejection
    fraction, remained unchanged during the postoperative period in both
    groups. Furthermore, 201Tl cardiac scintigraphy demonstrated no evidence of
    myocardial perfusion defects due to cryoablation in group A. In conclusion,
    myocardial damage induced by cryoablation is very minor and is not
    associated with any clinical impairment of cardiac function.

8. Iodice F; Tramontana S; Casella G; Tramontana R; Fortuna G; Germano A.
     Conization of the uterine cervix: two different surgical techniques.
   Journal of Chemotherapy, 1997 Apr, 9(2):133-4.
     (UI:  97319872)

9. Weinberger D; Fink-Cohen S; Axer-Siegel R.
     Rhegmatogenous retinal detachment operation after radial keratotomy.
   Acta Ophthalmologica Scandinavica, 1997 Apr, 75(2):214-5.
       (UI:  97341102)

Abstract: Radial keratotomy has recently been introduced for the correction of
    myopia. This procedure does not hinder progression of the
    pathophysiological changes in the myopic eye. We hereby describe a case of
    rhegmatogenous retinal detachment operation after radial keratotomy and
    present the operative considerations and refractive results.

  

August 26th, 1997

BIOSYS Database:

 

August 26th, 1997

Medline Database: